COM:IMUX
Immunic
- Stock
Last Close
1.11
22/11 21:00
Market Cap
115.30M
Beta: -
Volume Today
779.33K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.71M - | 633K 62.94% | -2.40M 479.70% | -1.33M 44.73% | ||||||||
average payables | 1.18M - | 5.75M 385.73% | 8.47M 47.22% | 6.07M 28.34% | 3.26M 46.20% | 658.50K 79.83% | 1.35M 104.33% | 3.06M 127.54% | 3.72M 21.59% | 4.01M 7.80% | 4.69M 16.87% | |
average receivables | 821.50K - | 1.90M 130.86% | 2.40M 26.73% | 1.33M 44.73% | ||||||||
book value per share | 2.94K - | 243.08 91.72% | 130.92 46.14% | 74.48 43.11% | 50.22 32.57% | 11.73 76.64% | 7.56 35.58% | 10.14 34.13% | 5.37 46.98% | 3.57 33.52% | 0.00 99.98% | |
capex per share | -105.22 - | -3.51 96.66% | -3.72 6.00% | -0.71 80.96% | -0.69 2.98% | -0.56 18.01% | -0.01 98.74% | -0.01 30.87% | -0.00 69.61% | -0.00 24.26% | -0.00 99.79% | |
capex to depreciation | -1.86 - | -1.30 30.21% | -1.76 35.94% | -0.31 82.55% | -0.69 123.19% | -0.82 19.64% | -1.10 33.95% | -3.74 240.33% | -0.79 78.94% | -1.45 84.53% | -3.01 106.87% | |
capex to operating cash flow | 0.05 - | 0.03 33.37% | 0.05 35.73% | 0.02 66.82% | 0.02 9.10% | 0.01 18.44% | 0.00 86.07% | 0.00 64.28% | 0.00 74.57% | 0.00 113.58% | 0.00 174.28% | |
capex to revenue | ||||||||||||
cash per share | 2.71K - | 254.73 90.59% | 132.65 47.92% | 76.45 42.37% | 57.10 25.31% | 12.58 77.97% | 3.80 69.77% | 8.14 113.95% | 3.67 54.87% | 3.66 0.41% | 0.00 99.97% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.06 - | 0.00 93.01% | 0.01 76.30% | 0.01 71.55% | 0.01 3.81% | |||||||
debt to equity | 0.07 - | 0.00 93.46% | 0.01 82.50% | 0.01 76.18% | 0.02 60.65% | |||||||
dividend yield | 0.01 - | |||||||||||
earnings yield | -4.83 - | -0.12 97.54% | -0.18 50.75% | -0.30 67.13% | -0.22 26.82% | -5.26 2,296.69% | -0.46 91.17% | -0.18 60.52% | -0.41 123.35% | -3.46 744.92% | -0.00 99.96% | |
enterprise value | -31.42M - | 298.00M 1,048.56% | 206.35M 30.76% | 76.54M 62.90% | 180.26M 135.50% | -5.44M 103.02% | 46.06M 946.12% | 112.73M 144.76% | 140.08M 24.26% | -60.64M 143.29% | 66.43B 109,663.14% | |
enterprise value over ebitda | 1.03 - | -5.92 676.53% | -3.96 33.12% | -1.85 53.15% | -3.49 88.39% | 0.16 104.57% | -1.25 879.47% | -2.30 84.98% | -1.53 33.67% | 1.13 174.10% | -669.54 59,228.30% | |
ev to operating cash flow | 1.10 - | -7.30 765.63% | -4.13 43.41% | -2.14 48.20% | -4.46 108.55% | 0.13 102.83% | -1.61 1,379.48% | -2.44 51.47% | -1.68 31.14% | 0.93 155.31% | -937.96 100,870.62% | |
ev to sales | ||||||||||||
free cash flow per share | -2.14K - | -105.23 95.07% | -83.16 20.97% | -46.30 44.32% | -41.23 10.95% | -41.31 0.21% | -3.70 91.04% | -2.95 20.24% | -3.52 19.22% | -2.05 41.77% | -0.00 99.92% | |
free cash flow yield | -4.45 - | -0.11 97.63% | -0.18 71.02% | -0.27 47.44% | -0.17 34.90% | -5.55 3,105.72% | -0.38 93.12% | -0.19 49.40% | -0.37 90.48% | -1.46 298.07% | -0.00 99.93% | |
graham net net | 2.34K - | 228.52 90.24% | 121.91 46.65% | 69.34 43.12% | 46.73 32.61% | 10.17 78.23% | 2.82 72.27% | 7.74 174.64% | 3.19 58.83% | 3.24 1.49% | 0.00 99.99% | |
graham number | 12.38K - | 805.95 93.49% | 493.66 38.75% | 295.80 40.08% | 243.01 17.85% | 101.67 58.16% | 27.69 72.76% | 25.30 8.64% | 21.78 13.91% | 19.74 9.35% | 0.01 99.97% | |
income quality | 0.88 - | 0.86 2.19% | 0.96 12.11% | 0.87 9.06% | 0.78 11.17% | 1.04 34.17% | 0.82 21.49% | 1.05 28.24% | 0.90 14.54% | 0.54 39.58% | 0.76 39.85% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0.50 Infinity% | 0.20 60.71% | 0.24 20.68% | 0 100% | 0 | |
interest coverage | -346.09 - | -114.78 - | ||||||||||
interest debt per share | 0.51 - | 0.04 91.47% | 0.04 3.25% | 0.08 95.13% | 0.00 99.98% | |||||||
inventory turnover | ||||||||||||
invested capital | 0.07 - | 0.00 93.46% | 0.01 82.50% | 0.01 76.18% | 0.02 60.65% | |||||||
market cap | 6.77M - | 400.24M 5,811.99% | 289.76M 27.60% | 136.54M 52.88% | 237.16M 73.70% | 7.88M 96.68% | 74.91M 850.50% | 239.50M 219.73% | 226.36M 5.49% | 44.55M 80.32% | 66.48B 149,137.12% | |
net current asset value | 38.69M - | 94.30M 143.74% | 78.33M 16.93% | 55.88M 28.66% | 47.78M 14.50% | 11.68M 75.55% | 24.64M 110.92% | 124.67M 406.00% | 93.00M 25.40% | 111.80M 20.21% | 27.17M 75.70% | |
net debt to ebitda | 1.25 - | 2.03 62.73% | 1.60 21.19% | 1.45 9.17% | 1.10 24.12% | 0.39 64.55% | 0.78 99.46% | 2.59 232.12% | 0.94 63.67% | 1.96 108.69% | 0.46 76.38% | |
net income per share | -2.32K - | -118.76 94.88% | -82.73 30.34% | -52.21 36.89% | -52.26 0.10% | -39.16 25.08% | -4.51 88.48% | -2.81 37.77% | -3.92 39.79% | -4.85 23.60% | -0.00 99.96% | |
operating cash flow per share | -2.03K - | -101.72 94.99% | -79.44 21.90% | -45.59 42.61% | -40.54 11.08% | -40.75 0.52% | -3.70 90.93% | -2.94 20.34% | -3.52 19.50% | -2.05 41.82% | -0.00 99.92% | |
payables turnover | ||||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | -0.70 - | -0.44 37.21% | -0.58 32.42% | -0.64 9.57% | -0.86 34.78% | -2.77 221.07% | -1.06 61.87% | -0.33 69.13% | -0.87 168.30% | -1.21 38.13% | -1.72 42.74% | |
revenue per share | ||||||||||||
roe | -0.79 - | -0.49 38.15% | -0.63 29.34% | -0.70 10.93% | -1.04 48.46% | -3.34 220.71% | -0.60 82.12% | -0.28 53.60% | -0.73 163.68% | -1.36 85.92% | -3.24 138.40% | |
roic | -0.76 - | -0.50 33.49% | -0.62 22.35% | -0.67 9.39% | -1.04 54.17% | -3.43 229.30% | -0.59 82.82% | -0.31 48.13% | -0.71 132.86% | -1.32 85.24% | -3.28 149.34% | |
sales general and administrative to revenue | ||||||||||||
shareholders equity per share | 2.94K - | 243.08 91.72% | 130.92 46.14% | 74.48 43.11% | 50.22 32.57% | 11.73 76.64% | 7.56 35.58% | 10.14 34.13% | 5.37 46.98% | 3.57 33.52% | 0.00 99.98% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | 41.42M - | 97.56M 135.56% | 82.33M 15.62% | 58.45M 29.01% | 50.04M 14.38% | 12.43M 75.17% | 25.39M 104.34% | 125.81M 395.47% | 94.14M 25.17% | 113.68M 20.75% | 28.93M 74.55% | |
tangible book value per share | 2.94K - | 243.08 91.72% | 130.92 46.14% | 74.48 43.11% | 50.22 32.57% | 11.73 76.64% | 3.29 71.97% | 8.03 144.27% | 3.98 50.45% | 3.57 10.24% | 0.00 99.98% | |
working capital | 39.01M - | 94.54M 142.35% | 78.43M 17.04% | 55.98M 28.62% | 47.84M 14.55% | 11.72M 75.50% | 25.16M 114.62% | 125.35M 398.24% | 93.59M 25.34% | 112.79M 20.52% | 27.80M 75.35% |
All numbers in USD (except ratios and percentages)